Mantle Cell Lymphoma: Identifying Patients With Indolent Disease Mantle Cell Lymphoma: Identifying Patients With Indolent Disease

Biomarkers are key in distinguishing between high-risk and indolent cases, allowing the latter to avoid unnecessary initial treatment.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news